市场调查报告书
商品编码
1533128
欧洲植髮市场预测至 2030 年 - 区域分析 - 按移植程序和部位Europe Hair Transplant Market Forecast to 2030 - Regional Analysis - by Procedure and Site of Transplantation |
2022年欧洲植髮市场价值为20.0458亿美元,预计到2030年将达到90.8933亿美元;预计 2022 年至 2030 年复合年增长率为 20.8%。
脱髮发生率的增加推动了欧洲毛髮移植市场
导致脱髮的原因有很多,例如休止期脱髮 (TE)、药物副作用、头癣和斑秃。 TE是一种常见的脱髮类型,由严重感染和长期疾病引起。例如,根据《医学与生命杂誌》上发表的一篇文章,休止期脱髮是 COVID-19 大流行的影响之一。 COVID-19 带来的药物和压力环境导致了 TE。
增加锂、β-受体阻断剂、华法林、肝素、安非他明和左旋多巴(Atamet、Larodopa、Sinemet)等药物的使用也会导致掉髮。此外,许多癌症化疗药物,包括阿霉素,经常导致快速脱髮。此外,头皮真菌感染是儿童脱髮的主要原因之一。根据 2023 年 PLOS ONE 发表的一篇文章,每年头癣占所有感染的 25% 至 30%。斑秃 (AA) 是一种导致脱髮的自体免疫疾病。根据《德国皮肤病学会杂誌》上发表的文章,40% 的患者在 20 岁时首次出现 AA 症状,83-88% 的患者在 40 岁时首次出现 AA 症状。各种因素正在推动市场成长。
欧洲植髮市场概况
欧洲植髮市场分为德国、英国、法国、义大利、西班牙和欧洲其他地区。该地区在植髮市场中占有重要份额,预计 2022 年至 2030 年复合年增长率将达到显着水准。欧洲市场的成长归因于捷克共和国、西班牙、德国、法国和英国等国家秃髮发病率的增加。根据名为“跨种族脱髮”的博客,西班牙约 43.6% 的男性人口秃顶或正在经历脱髮,其次是捷克共和国,约 43% 的男性人口秃顶或秃顶。根据同一来源,德国和法国分别有约 41% 和约 39% 的男性人口秃头或秃头。根据 Euromonitor International 的美容调查,2021 年约有 17% 的欧洲人口出现永久性脱髮或秃头。
欧洲植髮市场收入及 2030 年预测(百万美元)
欧洲毛髮移植市场细分
欧洲毛髮移植市场根据手术、移植部位和国家进行细分。根据手术方式,欧洲植髮市场分为手术植髮手术和非手术手术。到 2022 年,非手术手术细分市场将占据更大的市场份额。非手术程序细分为富血小板血浆非手术程序、雷射帽等。
从移植部位来看,欧洲植髮市场分为头皮移植、睫毛移植、眉毛移植、鬍鬚移植、胸部移植等。 2022 年,头皮移植领域占据最大的市场份额。
根据国家/地区,欧洲植髮市场分为英国、德国、法国、义大利、西班牙和欧洲其他地区。 2022年,德国在欧洲毛髮移植市场份额中占据主导地位。
DHI Global Europe Ltd.、Qunomedical GmbH.、The Follicle Clinic 和 HairMax Inc 是欧洲植髮市场的一些领先公司。
The Europe hair transplant market was valued at US$ 2,004.58 million in 2022 and is expected to reach US$ 9,089.33 million by 2030; it is estimated to RECORD a CAGR of 20.8% from 2022 to 2030.
Increasing Incidences of Hair Loss Fuel Europe Hair Transplant Market
Several reasons, such as Telogen Effluvium (TE), drug side effects, tinea capitis, and alopecia areata, are responsible for hair loss. TE is a common type of hair loss caused due to severe infection and prolonged illness. For instance, according to an article published in the Journal of Medicine and Life, telogen effluvium is one of the effects of the COVID-19 pandemic. Medications and stressful circumstances brought on by COVID-19 have resulted in causing TE.
Increasing use of medications such as lithium, beta-blockers, warfarin, heparin, amphetamines, and levodopa (Atamet, Larodopa, Sinemet) can also result in hair loss. In addition, many cancer chemotherapy drugs, including doxorubicin, frequently result in rapid hair loss. Furthermore, fungal infection of the scalp is one of the major reasons for hair loss in children. According to an article published in PLOS ONE in 2023, yearly tinea capitis accounts for 25 to 30% of all infections. Alopecia areata (AA) is an autoimmune disease that causes hair loss. As per the article published in the Journal of the German Society of Dermatology, 40% of patients experience their first AA symptom by age 20, and 83-88% experience it for the first time by age 40. Thus, increasing incidences of hair loss due to various factors are boosting the market growth.
Europe Hair Transplant Market Overview
The Europe hair transplant market is segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. This region holds a significant share of the hair transplant market and is expected to register a notable CAGR during 2022-2030. The market growth in Europe is attributed to the increasing incidence of baldness in countries such as the Czech Republic, Spain, Germany, France, and the UK. According to a blog named "Hair Loss across Ethnicities", ~43.6% of the male population is bald or experiencing hair loss in Spain, followed by the population in the Czech Republic where ~43% of the male population is bald or balding. According to the same source, ~41% and ~39% of the male population in Germany and France, respectively, is bald or balding. According to Euromonitor International's Beauty Survey, ~17% of the population in Europe reported permanent hair loss or balding in 2021.
Europe Hair Transplant Market Revenue and Forecast to 2030 (US$ Million)
Europe Hair Transplant Market Segmentation
The Europe hair transplant market is segmented based on procedures, site of transplantation, and country. Based on procedures, the Europe hair transplant market is bifurcated into surgical hair transplant procedures and non-surgical procedures. The non-surgical procedures segment held a larger market share in 2022. The surgical hair transplant procedures segment is sub segmented into Follicular Unite Strip Surgery (FUS), Follicular Unit Extraction (FUE), and other surgical procedures. The non-surgical procedures segment is sub segmented into platelet rich plasma non-surgical procedures, laser cap, and others.
In terms of site of transplantation, the Europe hair transplant market is categorized into scalp transplant, eyelash transplant, eyebrow transplant, beard/ moustache transplant, chest transplant, and others. The scalp transplant segment held the largest market share in 2022.
Based on country, the Europe hair transplant market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe hair transplant market share in 2022.
DHI Global Europe Ltd., Qunomedical GmbH., The Follicle Clinic, and HairMax Inc are some of the leading companies operating in the Europe hair transplant market.